Colgate-Palmolive Co Earnings - Q3 2026 Analysis & Highlights
Colgate-Palmolive reported broad-based organic growth and margin progress amid elevated costs, with performance supported by pricing, productivity, premium innovation, and advertising; management also discussed uneven category demand, regional and Hill’s results, and its priorities for the U.S. turnaround and 2027 planning.
Key financial results
Management described the quarter as delivering solid top- and bottom-line growth, with organic sales growth in all four categories and four of five divisions; base-business EPS exceeded expectations.
Free cash flow increased 7% through the third quarter, and Colgate returned $2.2 billion to shareholders year to date.
Management said year-to-date gross profit performance supported raising full-year gross-margin expectations from roughly flat to up year over year.
Year-to-date gross-margin drivers included material costs as an approximately 300-basis-point headwind, funding-the-growth productivity providing more than 290 basis points of offset, pricing contributing 80 basis points, and mix contributing about 20 basis points.
Overhead efficiencies improved by 90 basis points; management attributed the result to both underlying productivity and the Strategic Growth and Productivity Program (SGPP).
Hill’s gross margin increased 170 basis points; company EBIT margins were slightly higher year over year, and management said bottom-line EPS growth exceeded organic top-line growth.
The call did not state a total-company quarterly revenue figure, overall operating-margin change, or EPS growth rate.
Business segment results
Hill’s organic sales growth was 6.5% excluding private label, which management said was above expectations; growth came particularly from cat and wet products and market-share gains, while dog dry was relatively flat to down.
Hill’s therapeutic performance was strong: Prescription Diet Dog grew at a high-mid-single-digit rate and Prescription Diet Cat grew at a double-digit rate.
Hill’s Science Diet Cat grew at a high-single-digit rate, while Prescription Diet grew at a double-digit rate; management also cited strong growth in wet products across Science Diet and Prescription Diet.
Latin America organic sales increased 6%, including 3.9% volume growth and 2% pricing; Brazil grew at a double-digit rate, while Mexico faced consumer and retailer challenges.
Asia Pacific delivered approximately 5% organic growth, led by India’s double-digit growth; Greater China grew at a mid-single-digit rate, with Colgate China up high single digits and Hawley & Hazel up low single digits.
Europe and EMEA were described as strong contributors, with premium innovation supporting market-share gains in European markets; African markets also continued to perform well.
Management said the U.S. business had a strong quarter, but continued to focus on its turnaround and on improving toothpaste market share.
Capital allocation
Colgate returned $2.2 billion to shareholders year to date; the call did not specify the split between dividends and share repurchases.
Management described SGPP savings as funding both reinvestment in the business—including advertising, skills, AI, data, and analytics—and contributions to the bottom line.
The call provided no specific figures for dividends, buybacks, capital expenditures, or debt repayment.
Industry trends and dynamics
Management estimated global category growth at roughly 1.5% to 3%, with emerging markets growing around 3% to 5% and developed markets generally around 1.5% to 2.5%.
Category conditions remained sluggish overall: North America was the most pressured developed market, European categories were roughly flat, and the Hill’s category was subdued.
In China, management described the category as challenged, with very soft brick-and-mortar conditions and continued migration toward online and social-commerce platforms such as Douyin.
In Hill’s, cat, wet, and small-pet segments were identified as growth opportunities, while dog dry was relatively flat to down; management also noted continued migration toward smaller pets.
Management said more pricing and premium innovation could influence category growth, while emphasizing that growth opportunities differed by market and category.
Competitive landscape
Colgate reported toothpaste market-share improvement in the U.S., but management characterized the turnaround as a work in process and said the company needed to continue improving purchase conversion and execution.
Management cited strong market-share growth in Hill’s despite a challenging category and increased competition.
In Latin America, shares increased across toothpaste, toothbrushes, and mouthwash; Brazil’s double-digit growth was supported in part by advertising and premium oral-care execution.
In Europe, management pointed to market-share strength in premium oral care, including Elmex, whitening products, and the Colgate Total relaunch.
Management said Colgate’s advertising and innovation strategies were reflected in market-share growth across oral-care categories, including toothpaste, toothbrushes, and mouthwash.
The call discussed increased competition in Hill’s and competitive dynamics in categories, but did not identify specific competing companies.
Macroeconomic environment
Management expected elevated cost pressures to continue through the fourth quarter and into early 2027, citing raw materials, freight, and logistics.
Raw- and packaging-material pressures included resins, petrochemicals, pulp, and paper; management said commodity inflation would likely be a headwind entering 2027.
The company estimated 2026 cost inflation at roughly $300 million, plus or minus, consistent with its original range.
Management expected the fourth quarter to have the year’s highest year-over-year commodity inflation and the highest logistics costs, both in dollars and as a percentage of sales.
Foreign exchange had moved against Colgate, while management described recent currency movements as volatile and difficult to predict.
Management said tariffs were expected to peak in the fourth quarter; it also noted an insignificant tariff refund in Q3 and no anticipated additional refunds in Q4.
Consumer and market conditions varied by geography: management cited a difficult consumer backdrop and retailer-specific issues in Mexico, ongoing category challenges in China, and pressure in North America.
Growth opportunities and strategies
Management highlighted pricing, revenue growth management (RGM), funding-the-growth productivity, and SGPP as levers to offset elevated costs while supporting investment and profitable growth.
Colgate was expanding its proprietary PromoAI tools to improve promotional-spending decisions using historical data, alongside AI tools to accelerate product ideation and personalize content.
The U.S. strategy centers on scaling premium innovation while reinforcing core brands, strengthening marketing, and improving execution in digital, social, and emerging agentic-commerce channels.
Management said Colgate would increase the pace and impact of innovation, with a pipeline focused on premium opportunities, and improve its North American go-to-market structure to strengthen retailer and consumer connections.
Hill’s is targeting growth in cat, wet, small-pet, and therapeutic products; its Fresh offering is being rolled out deliberately, with expansion continuing through the rest of 2026 and into 2027.
Management identified emerging-market opportunities in India, Nigeria, Bangladesh, and Southeast Asia, with strategies including premiumization, stronger distribution, digital commerce, and applying learnings across markets.
Management said SGPP is expected to continue through the end of 2028, supporting a simpler and more agile organization.
Financial Guidance and Outlook
Colgate raised its full-year gross-margin outlook to expansion year over year, citing productivity and the company’s ability to offset elevated costs; Q4 commodity costs were largely locked in and included in guidance.
Management expected cost pressures to remain elevated in Q4 and the near term, with continued logistics pressure into next year; it did not provide 2027 financial guidance on the call.
Management said it would provide 2027 guidance in the first quarter of 2027 and was focused in the meantime on controllable levers and execution.
The company did not provide a specific 2027 forecast for sales, margins, EPS, cash flow, or capital allocation during the call.
Management anticipated that pricing would remain important as companies respond to cost pressures, but said the approach would vary by market and category; it did not give a 2027 pricing target.
Management expected global category trends to continue into Q4, while deferring discussion of 2027 category expectations until later.
